News

Serina Therapeutics advances POZ-VMAT2i into development for tardive dyskinesia: Huntsville, Alabama Thursday, July 31, 2025, 14:00 Hrs [IST] Serina Therapeutics, Inc. (Serina), a ...
Cellipont & CellVax expand partnership to advance cGMP manufacturing of personalized immunotherapy FK-GI101 for GI cancers: The Woodlands, Texas Thursday, July 31, 2025, 13:00 Hrs ...
Sandoz signs non-binding term sheet with Evotec to acquire its Just-Evotec Biologics in-house development and manufacturing for USD 300 million: Basel Thursday, July 31, 2025, 12: ...
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases: Maryland Thursday, July 31, 2025, 11:00 Hrs [IST] Researchers ...
US FDA takes steps to restrict 7-hydroxymitragynine opioid products threatening American consumers: Silver Spring, Maryland Thursday, July 31, 2025, 09:00 Hrs [IST] The US Food an ...
TN PTA appeals to Union Finance Minister for complete exemption of all life-saving medicines from GST: Peethaambaran Kunnathoor, Chennai Thursday, July 31, 2025, 08:00 Hrs [IST] T ...
VGGS commissioned in Gujarat: Dr. H G Koshia: Shardul Nautyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] Out of the total 376 projects in ...
Saudi Arabia invites Indian pharma companies for strategic partnerships & investment opportunities: Shardul Nautiyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] In a major bo ...
DBT engaged in various initiatives on alternatives to animal testing: Minister: Our Bureau, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] Even as the Department of Biotechnol ...
SJM demands elimination of animal studies, more clarity on Biosimilar Guidelines: Gireesh Babu, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] The Swadeshi Jagran Manch (SJM), ...
On July 24, India and the UK have signed a Free Trade Agreement in London in the presence of Indian Prime Minister Narendra Modi and UK premier Keir Starmer. The much-awaited Indo-UK FTA marks a ...
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...